Aporphine esters and their use in therapy

Aporphine esters and their use in therapy

New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wikstrom, Hakan, Dijkstra, Durk, Cremers, Thomas, Andren, Per Erik, Marchais, Sandrine, Jurva, Ulrik
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Wikstrom, Hakan
Dijkstra, Durk
Cremers, Thomas
Andren, Per Erik
Marchais, Sandrine
Jurva, Ulrik
description New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07332503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07332503</sourcerecordid><originalsourceid>FETCH-uspatents_grants_073325033</originalsourceid><addsrcrecordid>eNrjZNB0LMgvKsjIzEtVSC0uSS0qVkjMS1EoyUjNLFIoLU5VyMwDcYoSCyp5GFjTEnOKU3mhNDeDgptriLOHbmlxQWJJal5JcXx6USKIMjA3NjYyNTA2JkIJAMrWKVg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Aporphine esters and their use in therapy</title><source>USPTO Issued Patents</source><creator>Wikstrom, Hakan ; Dijkstra, Durk ; Cremers, Thomas ; Andren, Per Erik ; Marchais, Sandrine ; Jurva, Ulrik</creator><creatorcontrib>Wikstrom, Hakan ; Dijkstra, Durk ; Cremers, Thomas ; Andren, Per Erik ; Marchais, Sandrine ; Jurva, Ulrik ; Axon Biochemicals B.V</creatorcontrib><description>New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7332503$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7332503$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Wikstrom, Hakan</creatorcontrib><creatorcontrib>Dijkstra, Durk</creatorcontrib><creatorcontrib>Cremers, Thomas</creatorcontrib><creatorcontrib>Andren, Per Erik</creatorcontrib><creatorcontrib>Marchais, Sandrine</creatorcontrib><creatorcontrib>Jurva, Ulrik</creatorcontrib><creatorcontrib>Axon Biochemicals B.V</creatorcontrib><title>Aporphine esters and their use in therapy</title><description>New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNB0LMgvKsjIzEtVSC0uSS0qVkjMS1EoyUjNLFIoLU5VyMwDcYoSCyp5GFjTEnOKU3mhNDeDgptriLOHbmlxQWJJal5JcXx6USKIMjA3NjYyNTA2JkIJAMrWKVg</recordid><startdate>20080219</startdate><enddate>20080219</enddate><creator>Wikstrom, Hakan</creator><creator>Dijkstra, Durk</creator><creator>Cremers, Thomas</creator><creator>Andren, Per Erik</creator><creator>Marchais, Sandrine</creator><creator>Jurva, Ulrik</creator><scope>EFH</scope></search><sort><creationdate>20080219</creationdate><title>Aporphine esters and their use in therapy</title><author>Wikstrom, Hakan ; Dijkstra, Durk ; Cremers, Thomas ; Andren, Per Erik ; Marchais, Sandrine ; Jurva, Ulrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_073325033</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Wikstrom, Hakan</creatorcontrib><creatorcontrib>Dijkstra, Durk</creatorcontrib><creatorcontrib>Cremers, Thomas</creatorcontrib><creatorcontrib>Andren, Per Erik</creatorcontrib><creatorcontrib>Marchais, Sandrine</creatorcontrib><creatorcontrib>Jurva, Ulrik</creatorcontrib><creatorcontrib>Axon Biochemicals B.V</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Wikstrom, Hakan</au><au>Dijkstra, Durk</au><au>Cremers, Thomas</au><au>Andren, Per Erik</au><au>Marchais, Sandrine</au><au>Jurva, Ulrik</au><aucorp>Axon Biochemicals B.V</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Aporphine esters and their use in therapy</title><date>2008-02-19</date><risdate>2008</risdate><abstract>New aporphine derivatives are disclosed which have formula (I) and the physiologically acceptable salts thereof. Said derivatives may be used for the treatment of Parkinson's disease, hemicrania, restless legs syndrome (RLS), sexual dysfunction in men and women, hyperprolactemia and psychotic disorders, and/or evaluation of Parkinson's disease. Processes for the preparation of such derivatives are also disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07332503
source USPTO Issued Patents
title Aporphine esters and their use in therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T01%3A26%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Wikstrom,%20Hakan&rft.aucorp=Axon%20Biochemicals%20B.V&rft.date=2008-02-19&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07332503%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true